Page last updated: 2024-10-17

n(1)-methylnicotinamide and Diabetes Mellitus

n(1)-methylnicotinamide has been researched along with Diabetes Mellitus in 2 studies

N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.

Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, M1
Chu, J1
Gu, Y1
Shi, H1
Zhang, R1
Wang, L1
Chen, J1
Shen, L1
Yu, P1
Chen, X1
Ju, W1
Wang, Z1
Przygodzki, T1
Kazmierczak, P1
Sikora, J1
Watala, C1

Other Studies

2 other studies available for n(1)-methylnicotinamide and Diabetes Mellitus

ArticleYear
Serum N1-Methylnicotinamide is Associated With Coronary Artery Disease in Chinese Patients.
    Journal of the American Heart Association, 2017, 02-07, Volume: 6, Issue:2

    Topics: Aged; Biomarkers; Body Mass Index; China; Chromatography, Liquid; Comorbidity; Coronary Angiography;

2017
1-methylnicotinamide effects on the selected markers of endothelial function, inflammation and haemostasis in diabetic rats.
    European journal of pharmacology, 2010, Aug-25, Volume: 640, Issue:1-3

    Topics: Animals; Biomarkers; Diabetes Mellitus; Endothelium, Vascular; Hemostasis; Hypolipidemic Agents; Inf

2010